CUtLASS 1 findings — no clinical advantage between 1st- and 2nd-generation antipsychotics
Insomnia medication ramelteon shows no potential for abuse or adverse effects
Aripiprazole and lithium: Neuroleptic malignant syndrome
Divalproex ER for acute mania
CUtLASS 1 author commentary
Lamotrigine vs. citalopram for bipolar depression
Atomoxetine for hyperactivity in autism
Modafinil and unconstrained motor activity in schizophrenia
Hair loss with lamotrigine
From the FDA